Bixiye
P53-24 MagellanRx Management, a Prime Therapeutics Company (UM) Program: Medical Drug Updates
Taariikhda barnaamijka Dhaqangalayso Agosto 01, 2024
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 1531 - 1540 ee natiijooyinka 3289
Bixiye
2024 August Bulletins
Taariikhda barnaamijka Dhaqangalayso Agosto 01, 2024
Bixiye
P51-24 Inpatient Admission, Concurrent Review, and Discharge Submission Process Change for Commercial & Medicare Advantage Members
Taariikhda barnaamijka Dhaqangalayso Agosto 01, 2024
Bixiye
QP59-24 Commercial Pharmacy Benefit Exclusion for Select Medications
Taariikhda dhaqangalka Barnaamijka: Jul 24, 2024
Bixiye
QP60-24 Minnesota Department of Health Provider Data Audit
Taariikhda dhaqangalka Barnaamijka: Jul 24, 2024
Bixiye
QP61-24 Reimbursement Policies and Coding for Durable Medical Equipment & Supplies
Taariikhda dhaqangalka Barnaamijka: Jul 24, 2024
Bixiye
QP55R2-23 Change in Processing for Replacement Claims
Taariikhda dhaqangalka Barnaamijka: Jul 24, 2024
Bixiye
QP54-24 MHCP Pharmacy Benefit Exclusion for DefenCath®
Taariikhda dhaqangalka Barnaamijka: Jul 10, 2024
Bixiye
QP57-24 Commercial and MHCP Pharmacy Benefit Exclusion for Beqvez® and Hepzato™
Taariikhda dhaqangalka Barnaamijka: Jul 10, 2024
Bixiye
QP55-24 MHCP Pharmacy Benefit Update: Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective August 1, 2024
Taariikhda dhaqangalka Barnaamijka: Jul 10, 2024